Issued Patents All Time
Showing 51–75 of 112 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9486536 | Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer | William J. McBride, Nalini Sathyanarayan, Christine Mazza-Ferreira, David M. Goldenberg | 2016-11-08 |
| 9480756 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2016-11-01 |
| 9481732 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2016-11-01 |
| 9475884 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2016-10-25 |
| 9458242 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2016-10-04 |
| 9388237 | Immunoconjugates with an intracellularly-cleavable linkage | — | 2016-07-12 |
| 9375489 | Antibody-SN-38 immunoconjugates with a CL2A linker | Jonathan B. Gale, Nicholas J. Holman, David M. Goldenberg | 2016-06-28 |
| 9345783 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2016-05-24 |
| 9283286 | Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer | William J. McBride, Nalini Sathyanarayan, Christine Mazza-Ferreira, David M. Goldenberg | 2016-03-15 |
| 9272057 | Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy | David M. Goldenberg | 2016-03-01 |
| 9238084 | Anti-mucin antibodies for early detection and treatment of pancreatic cancer | Donglin Liu, David V. Gold, Chien-Hsing Chang, David M. Goldenberg | 2016-01-19 |
| 9233172 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2016-01-12 |
| 9226973 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2016-01-05 |
| 9198978 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2015-12-01 |
| 9138485 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2015-09-22 |
| 9133268 | Immunoconjugates with an intracellularly-cleavable linkage | — | 2015-09-15 |
| 9107960 | Antibody-SN-38 immunoconjugates with a CL2A linker | Jonathan B. Gale, Nicholas J. Holman, David M. Goldenberg | 2015-08-18 |
| 9102735 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2015-08-11 |
| 9095628 | Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer | William J. McBride, Nalini Sathyanarayan, Christine Mazza-Ferreira, David M. Goldenberg | 2015-08-04 |
| 9028833 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2015-05-12 |
| 9005613 | Anti-mucin antibodies for early detection and treatment of pancreatic cancer | Donglin Liu, David V. Gold, Chien-Hsing Chang, David M. Goldenberg | 2015-04-14 |
| 8999344 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2015-04-07 |
| 8992931 | Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy | David M. Goldenberg | 2015-03-31 |
| 8889835 | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | Sung-Ju Moon, David M. Goldenberg, Chien-Hsing Chang | 2014-11-18 |
| 8877202 | Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer | William J. McBride, Nalini Sathyanarayan, Christine Mazza-Ferreira, David M. Goldenberg | 2014-11-04 |